{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:23:19Z","timestamp":1787851399205,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.biopha.2024.116705","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:03:54Z","timestamp":1715036634000},"page":"116705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The discovery of a novel pyrrolo[2,3-b]pyridine as a selective CDK8 inhibitor offers a new approach against psoriasis"],"prefix":"10.1016","volume":"175","author":[{"given":"Yao Yao","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jie","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cen Cen","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116705_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.116705_bib2","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.3390\/ijms20184347","article-title":"Risk factors for the development of psoriasis","volume":"20","author":"Kamiya","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116705_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/jdv.14949","article-title":"Generalized pustular psoriasis: a review and update on treatment","volume":"32","author":"Hoegler","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.biopha.2024.116705_bib4","article-title":"Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis","volume":"2011","author":"Qazi","year":"2011","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.biopha.2024.116705_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2008.04.005","article-title":"Cytokines and anticytokines in psoriasis","volume":"394","author":"Pietrzak","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2024.116705_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/1523-1747.ep12514689","article-title":"Localization of neutrophil-activating peptide-1\/interleukin-8-immunoreactivity in normal and psoriatic skin","volume":"96","author":"Sticherling","year":"1991","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.biopha.2024.116705_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/107999099313866","article-title":"Regulation of interleukin-8 gene expression","volume":"19","author":"Roebuck","year":"1999","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.biopha.2024.116705_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/jid.2014.295","article-title":"Immunogenicity of biotherapy used in psoriasis: the science behind the scenes","volume":"135","author":"Jullien","year":"2015","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.biopha.2024.116705_bib9","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.0022-202X.2005.23735.x","article-title":"Differential expression of phosphorylated NF-kappaB\/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept","volume":"124","author":"Lizzul","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2024.116705_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/187221309787158399","article-title":"NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis","volume":"3","author":"Tsuruta","year":"2009","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"key":"10.1016\/j.biopha.2024.116705_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1600-0560.2007.00841.x","article-title":"Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study","volume":"35","author":"Abdou","year":"2008","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.biopha.2024.116705_bib12","doi-asserted-by":"crossref","first-page":"25487","DOI":"10.1074\/jbc.M111.240671","article-title":"Tumor necrosis factor alpha-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor kappaB","volume":"286","author":"Johansen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.116705_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ebiom.2018.09.031","article-title":"Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-\u03baB and improving mitochondrial function","volume":"36","author":"Yu","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2024.116705_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5152\/npa.2015.8801","article-title":"The activation of RAGE and NF-KB in nerve biopsies of patients with axonal and vasculitic neuropathy","volume":"52","author":"Bekircan-Kurt","year":"2015","journal-title":"Noro Psikiyatr Ars"},{"key":"10.1016\/j.biopha.2024.116705_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ncb1560","article-title":"Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation","volume":"9","author":"Gareus","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2024.116705_bib16","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1476-5381.2009.00402.x","article-title":"Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and proresolution agents","volume":"158","author":"Leitch","year":"2009","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116705_bib17","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nm1468","article-title":"Cyclin dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis","volume":"12","author":"Rossi","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2024.116705_bib18","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/eji.200939664","article-title":"The cyclin-dependent kinase inhibitor R-Roscovitine down-regulates Mcl-1 to override pro-inflammatory signalling and drive neutrophil apoptosis","volume":"40","author":"Leitch","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2024.116705_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/trns.1.1.12373","article-title":"CDK8: a positive regulator of transcription","volume":"1","author":"Galbraith","year":"2010","journal-title":"Transcription"},{"key":"10.1016\/j.biopha.2024.116705_bib20","article-title":"Angel or Devil ? - CDK8 as the new drug target","volume":"5","author":"Wu","year":"2021","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.biopha.2024.116705_bib21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2013.04.048","article-title":"HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia","volume":"153","author":"Matthew","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.116705_bib22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cell.2009.09.035","article-title":"Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways","volume":"139","author":"Alarc\u00f3n","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.116705_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.canlet.2014.10.008","article-title":"Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt\/\u03b2-catenin signaling pathway","volume":"356","author":"Xu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2024.116705_bib24","first-page":"24275","article-title":"CDK8 as the STAT1 serine 727 kinase?","volume":"2","author":"Herrmann-Lingen","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.biopha.2024.116705_bib25","first-page":"393","article-title":"Mediator kinase module and human tumorigenesis","volume":"50","author":"Clark","year":"2015","journal-title":"Crit. Rev. Biochem Mol. Biol."},{"key":"10.1016\/j.biopha.2024.116705_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tibs.2005.03.002","article-title":"The mammalian Mediator complex and its role in transcriptional regulation","volume":"30","author":"Conaway","year":"2005","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.biopha.2024.116705_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrm3951","article-title":"The Mediator complex: a central integrator of transcription","volume":"16","author":"Allen","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2024.116705_bib28","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nchembio.2458","article-title":"Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells","volume":"13","author":"Johannessen","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2024.116705_bib29","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1021\/acs.jmedchem.2c00356","article-title":"Discovery and anti-inflammatory activity evaluation of a novel CDK8 inhibitor through upregulation of IL-10 for the treatment of inflammatory bowel disease In Vivo","volume":"65","author":"Yan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116705_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106402","article-title":"A novel CDK8 inhibitor with poly-substituted pyridine core: Discovery and anti-inflammatory activity evaluation in vivo","volume":"133","author":"Chen","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2024.116705_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112459","article-title":"Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment","volume":"146","author":"Lin","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.116705_bib32","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/1535-7163.MCT-19-0789","article-title":"Selective and potent CDK8\/19 inhibitors enhance NK-Cell Activity and promote tumor surveillance","volume":"19","author":"Marco","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2024.116705_bib33","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1073\/pnas.1710467114","article-title":"CDK8\/19 mediator kinases potentiate induction of transcription by NF\u03baB","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2024.116705_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.celrep.2019.03.031","article-title":"PCNA-mediated degradation of p21 coordinates the DNA damage response and cell cycle regulation in individual cells","volume":"27","author":"Sheng","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2024.116705_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40659-020-00316-0","article-title":"Daphnetin inhibits proliferation and inflammatory response in human HaCat keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice","volume":"53","author":"Gao","year":"2020","journal-title":"Biol. Res"},{"key":"10.1016\/j.biopha.2024.116705_bib36","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.3390\/jcm10173880","article-title":"The defect in regulatory T cells in psoriasis and therapeutic approaches","volume":"10","author":"Kanda","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2024.116705_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw2707","article-title":"Conversion of antigen-specific effector\/memory T cells into Foxp3-expressing Treg cells by inhibition of CDK8\/19","volume":"4","author":"Akamatsu","year":"2019","journal-title":"Sci. Immunol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224005894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224005894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T19:39:27Z","timestamp":1741030767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224005894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":37,"alternative-id":["S0753332224005894"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116705","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The discovery of a novel pyrrolo[2,3-b]pyridine as a selective CDK8 inhibitor offers a new approach against psoriasis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116705"}}